Compugen Ltd. (BOATS:CGEN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Sanford S Zweifach Other companies: Carisma Therapeutics, Inc. (Director · Mar 7, 2023 – Jun 26, 2024 · Past); ESSA Pharma Inc (Director · Oct 1, 2020 – Mar 25, 2024 · Past); Anthera Pharmaceuticals Inc (Director · Mar 25, 2013 – May 21, 2015 · Past) | Director · Since at least Mar 18, 2026 |
| David Silberman Other companies: Nasus Pharma Ltd. (Board Member · Since at least Mar 18, 2026); Oramed Pharmaceuticals Inc. (Chief Financial Officer · Jul 5, 2021 – Jan 4, 2024 · Past) | Chief Financial Officer · Since at least Mar 18, 2026 |
| Michele Holcomb Other companies: Kimball Electronics, Inc. (Director · Since at least Nov 7, 2019); Cardinal Health, Inc. (EVP - Strategy & Corp. Dev. · Jan 3, 2017 – Aug 15, 2022 · Past) | Director · Since at least Feb 12, 2026 |
| Anat Cohen-Dayag Other companies: Gamida Cell Ltd (Director · Jan 28, 2022 – Feb 8, 2023 · Past) | Executive Chair · Since at least Mar 2, 2026 |
| Dorit Amitay | Vice President, Human Resources · Since at least Nov 5, 2026 |
| Eran Ben Dor | General Counsel and Corporate Secretary · Since at least Nov 5, 2026 |
| Eran Ophir | President and CEO · Since at least Mar 18, 2026 |
| Eran Perry | Managing Director and Chairman of the Investment Committee, MII Fund & Labs · Since at least Mar 18, 2026 |
| Gilead Halevy | Director · Since at least Mar 18, 2026 |
| Lindsey Trickett | Head of Investor Relations and Corporate Communications · Since at least Nov 3, 2026 |
| Mathias Hukkelhoven | Director · Since at least Jul 29, 2026 |
| Michelle Mahler | Chief Medical Officer · Since at least Mar 18, 2026 |
| Pierre Ferre | Chief Operating Officer · Since at least Mar 18, 2026 |
| Russo Sharon Kredo | SVP, Research & Discovery · Since at least Mar 18, 2026 |
| Savitzky Kinneret Livnat | Director · Since at least Mar 18, 2026 |
| Sharon Kredo-Russo | Senior Vice President, Research & Discovery · Since at least Nov 5, 2026 |
| Yvonne Naughton | Ph.D.Vice President, Head of Investor Relations and Corporate CommunicationsEmail · Since at least Dec 17, 2025 |
| Zurit Levine | Senior Vice President, Business Development · Since at least Mar 18, 2026 |